Primary signet-ring cell carcinoma of the urinary bladder: A clinicopathologic and immunohistochemical study of 5 cases

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 1, 2009, Pages 18-22

  Del Sordo, Rachele ^a,b   Bellezza, Guido ^a   Colella, Renato ^a   Mameli, Maria Grazia ^a   Sidoni, Angelo ^a   Cavaliere, Antonio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b POLICLINICO MONTELUCE   (Italy)

Author keywords

Cinoma; Immunohistochemistry; Secondary tumors; Signet ring cell car

Indexed keywords

ALCIAN BLUE; BETA CATENIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 12; CYTOKERATIN 20; CYTOKERATIN ANTIBODY; EOSIN; ESTROGEN RECEPTOR; HEMATOXYLIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63; THROMBOMODULIN; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER; VILLIN; VIMENTIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOGENESIS; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; METASTASIS; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; SIGNET RING CARCINOMA; BLADDER TUMOR; CASE REPORT; IMMUNOPHENOTYPING; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 58749103893     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31816a7466     Document Type: Article

References (38)

1. Dahm P, Gschwend JE. Malignant non-urothelial neoplasm of the urinary bladder: a review. Eur Urol. 2003;44:672-681. (Pubitemid 37542925)
2. Eble JN, Sauter G, Epstein JI, et al. Tumours of the urinary system. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs WHO. Lyon: IARC Press; 2004:128-130.
3. Torenbeek R, Koot RAC, Blomjous CEM, et al. Primary signet-ring cell carcinoma of the urinary bladder. Histopathology. 1996;28: 33-40. (Pubitemid 26040139)
4. Saphir O. Signet-ring cell carcinoma of the urinary bladder. Am J Pathol. 1955;31:223-231.
5. Erdogru T, Kilicaslan I, Esen T, et al. Primary signet ring cell carcinoma of the urinary bladder. Urol Int. 1995;55: 34-37.
6. Mutaguci K, Araki T, Shirane T, et al. Primary signet-ring cell carcinoma of the urinary bladder: a case report. Nishinihon J Urol. 1997;59:911-914. (Pubitemid 28030733)
7. Bates AW, Baithun SI. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology. 2000;36:32-40.
8. Melicow MM. Tumours of the urinary bladder. A clinicopathological analysis of over 2500 specimens and biopsies. J Urol. 1955;74: 498-521.
9. Alroy J, Roganovic D, Banner BF, et al. Primary adenocarcinomas of the human urinary bladder: histochemical, immunological and ultrastructural studies. Virchows Arch (Pathol Anat). 1981;393: 165-181.
10. Epstein JI, Woodruff J. Prostatic carcinomas with endometroid features: a light microscopic and immunohistochemical study of 10 cases. Cancer. 1986;57:111-119.
11. Young RH, Johnston WH. Serous adenocarcinoma of the uterus metastatic to the urinary bladder mimicking primary bladder neoplasia. Am J Surg Pathol. 1990;14:877-880.
12. Murphy WH, Grignon DJ, Perlman EJ. Tumors of the kidney, bladder, and related urinary structures. AFIP Atlas of Tumor Pathol. 2004;1:304-309. Series 4.
13. Yamamoto S, Ito T, Akiyama A, et al. Primary signet-ring cell carcinoma of the urinary bladder inducing renal failure. Int J Urol. 2001;8:190-193. (Pubitemid 34225075)
14. Braun EV, Ali M, Fayemi AO, et al. Primary signet-ring cell carcinoma of the urinary bladder: review of the literature and report of a case. Cancer. 1981;47:1430-1435. (Pubitemid 11090513)
15. Mostofi FK. Potentialities of bladder epithelium. J Urol. 1954;7: 705-714.
16. Edwards PD, Hurm RA, Jaeschke WA. Conversion of cystitis glandularis to adenocarcinoma. J Urol. 1972;108:568-570.
17. Kunze E, Francksen B. Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study. Urol Res. 2002; 30:66-78.
18. Mostofi FK, Thompson RV, Dean AL. Mucous adenocarcinoma of the urinary bladder. Cancer. 1955;8:741-758.
19. Tiltman AJ, Maytom PAN. Adenocarcinoma of the urinary bladder: histochemical distinction between urachal and metastatic carcinomas. S Afr Med J. 1977;51:74-75.
20. Wells M, Anderson K. Mucin histochemisty of cystitis glandularis and primary adenocarcinoma of the urinary bladder. Arch Pathol Lab Med. 1985;109:59-61. (Pubitemid 15060870)
21. Newbould M, McWilliam LJ. A study of vesical adenocarcinoma, intestinal metaplasia and related lesion using mucin histochemistry. Histopathology. 1990;17:225-230. (Pubitemid 20275964)
22. Nakaniski K, Tominaga S, Kawai T, et al. Mucin histochemistry in primary adenocarcinoma of the urinary bladder (of urachal or vesicular origin) and metastatic adenocarcinoma originating in the colorectum. Pathol Int. 2000;50:207-303. (Pubitemid 30441281)
23. Wang HL, Lu DW, Yerian LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001;25: 1380-1387.
24. Tamboli P, Mohsin SK, Hailemarian S, et al. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation. A report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med. 2002;126:1057-1063.
25. Raspollini MR, Nesi G, Baroni G, et al. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl Immunohistochem Mol Morphol. 2005;13:358-362. (Pubitemid 41697399)
26. Torenbeek R, Lagendijk JH, Van Diest PJ, et al. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. Histopathology. 1998;32: 20-27. (Pubitemid 28122409)
27. Goldstein NS, Long A, Kuan SF, et al. Colon signet-ring cell adenocarcinoma: immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas. Appl Immunohistochem Mol Morphol. 2000;8:183-188. (Pubitemid 30677903)
28. Merchant SH, Amin MB, Tamboli P, et al. Primary signet-ring cell carcinoma of lung. Immunohistochemical study and comparison with non pulmonary signet-ring cell carcinomas. Am J Surg Pathol. 2001;25:1515-1519. (Pubitemid 33096966)
29. Tot T. The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet-ring cell carcinoma of the gastrointestinal tract. APMIS. 2000;108:467-472. (Pubitemid 30663928)
30. Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121:884-892. (Pubitemid 38669284)
31. Ordóñez NG. Value of thrombomodulin immunostaining in the diagnosis of transitional cell carcinoma: a comparative study with carcinoembryonic antigen. Histopathology. 1997;31:517-524.
32. Ordóñez NG. Thrombomodulin expression in transitional cell carcinoma. Am J Clin Pathol. 1998;110:385-390. (Pubitemid 28406998)
33. Hao X, Tomlison I, Ilyas M, et al. Reciprocity between membranous and nuclear expression of b-catenin in colorectal tumours. Virchows Arch. 1997;431:167-172. (Pubitemid 27440360)
34. Moll R, Robine S, Dudouet B, et al. Villin: a cytoskeletal protein and a differentiation expressed in some adenocarcinomas. Virchows Arch. 1987;54:155-169. (Pubitemid 17164663)
35. Kunju LP, Mehra R, Snyder M, et al. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34bE12), and/or p63. An optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma. Am J Clin Pathol. 2006;125:675-681.
36. Varma M, Morgan M, Amin MB, et al. High molecular weight cytokeratin antibody (clone 34bE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology. 2003;42:167-172. (Pubitemid 36237849)
37. Epstein JI, Kuhajda FP, Lieberman PH. Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder. Hum Pathol. 1986;17:939-942.
38. Torbenson M, Dhir R, Nangia A, et al. Prostatic carcinoma with signet ring cells: a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature. Mod Pathol. 1998;11:552-559. (Pubitemid 28280719)